Merhabalar sevgili okuyucularım, dünyamız gün geçtikçe değişmeye devam ediyor. Bir yandan blockchain gibi teknolojiler gün geçtikçe hayatımıza adapte olmaya devam ederken bir yandan insanlar olarak Covid-19

ABOUT CLINTEX ClinTex will revolutionize the entire drugs industry through its modern innovation. The team of ClinTex aims to create a pharmaceutical company that will facilitate clinical Trials intelligence

Disrupting the clinical trials process sounds perfect for blockchain and the power of tokenisation will again prove its worth. Anything that can speed up the process of launching and releasing much needed

Neill Barron, Director de Servicios de Datos Clínicos de Clintex, hablará en esta entrevista con TechBullion sobre cómo la Clintex CTi reducirá significativamente el costo de los nuevos medicamentos, a

The annual financing of the clinical trials market is more than $ 100 billion and if you take a separate unit, the drug is subject to a clinical trial, its estimated value is about half a billion. The

ClinTex, the company behind CTi, say it will achieve this by revolutionising how clinical trials are conducted through the innovative use of a combination of smart contracts both on their private consortium

Currently clinical trials are very expensive despite the use of technologies, the rising costs are directly related to the processes, research and development of the clinical trials. With the increasing

Clinical trials are very risky and the processes require precise processes, that’s the reasons clinical trials are very costly due to the research and development processes. The processes can last a long

Clinical trials cover a wide range of different types of researches, ranging from testing new medicines to developing a more complicated design to forecast the outcome of the combinatorial approach to